Cadrenal Therapeutics, Inc., 2026-07-15
An SEC Form D private-offering notice from Ponte Vedra, FL, a $8,843,849 filer-stated offering target in Biotech. Filed 2026-07-15. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Late-stage biopharmaceutical company developing therapies for immune and thrombotic conditions, including tecarfarin, an oral anticoagulant in Phase 3 trials.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Cyclops, Inc., 2026-07-15, $20M, Miami, FL
- SelSym Biotech, Inc., 2026-07-15, $1.5M, Durham, NC
- NatGold Digital Ltd., 2026-07-15, $1M, Coral Cables, FL
- LYNCH REGENERATIVE MEDICINE, LLC, 2026-07-15, $17.5M, Franklin, TN
- FreeCast, Inc., 2026-07-15, $23.7M, Orlando, FL
- Cellular Logistics, Inc., 2026-07-15, $100K, Madison, WI
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.